252 related articles for article (PubMed ID: 31997152)
1. FGF21 Protects Dopaminergic Neurons in Parkinson's Disease Models Via Repression of Neuroinflammation.
Fang X; Ma J; Mu D; Li B; Lian B; Sun C
Neurotox Res; 2020 Mar; 37(3):616-627. PubMed ID: 31997152
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
3. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
Rai SN; Yadav SK; Singh D; Singh SP
J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
[TBL] [Abstract][Full Text] [Related]
4. Noscapine Prevents Rotenone-Induced Neurotoxicity: Involvement of Oxidative Stress, Neuroinflammation and Autophagy Pathways.
Jayaraj RL; Beiram R; Azimullah S; M F NM; Ojha SK; Adem A; Jalal FY
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361780
[TBL] [Abstract][Full Text] [Related]
5. Anti-neuroinflammatory, protective effects of the synthetic microneurotrophin BNN-20 in the advanced dopaminergic neurodegeneration of "weaver" mice.
Panagiotakopoulou V; Botsakis K; Delis F; Mourtzi T; Tzatzarakis MN; Dimopoulou A; Poulia N; Antoniou K; Stathopoulos GT; Matsokis N; Charalampopoulos I; Gravanis A; Angelatou F
Neuropharmacology; 2020 Mar; 165():107919. PubMed ID: 31877321
[TBL] [Abstract][Full Text] [Related]
6. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease.
Haque ME; Azam S; Akther M; Cho DY; Kim IS; Choi DK
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925146
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease.
Elgueta D; Aymerich MS; Contreras F; Montoya A; Celorrio M; Rojo-Bustamante E; Riquelme E; González H; Vásquez M; Franco R; Pacheco R
Neuropharmacology; 2017 Feb; 113(Pt A):110-123. PubMed ID: 27693549
[TBL] [Abstract][Full Text] [Related]
8. FTY720 Inhibits MPP
Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
[TBL] [Abstract][Full Text] [Related]
9. D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation.
Li Y; Liu W; Li L; Hölscher C
Eur J Pharmacol; 2017 Feb; 797():162-172. PubMed ID: 27913104
[TBL] [Abstract][Full Text] [Related]
10. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease.
Shao QH; Chen Y; Li FF; Wang S; Zhang XL; Yuan YH; Chen NH
Acta Pharmacol Sin; 2019 Dec; 40(12):1503-1512. PubMed ID: 31388087
[TBL] [Abstract][Full Text] [Related]
11. Achyranthes bidentata polypeptide protects dopaminergic neurons from apoptosis in Parkinson's disease models both in vitro and in vivo.
Peng S; Wang C; Ma J; Jiang K; Jiang Y; Gu X; Sun C
Br J Pharmacol; 2018 Feb; 175(4):631-643. PubMed ID: 29181847
[TBL] [Abstract][Full Text] [Related]
12. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
[TBL] [Abstract][Full Text] [Related]
13. Dynamic changes of activated AHR in microglia and astrocytes in the substantia nigra-striatum system in an MPTP-induced Parkinson's disease mouse model.
Zhou Y; Zhao WJ; Quan W; Qiao CM; Cui C; Hong H; Shi Y; Niu GY; Zhao LP; Shen YQ
Brain Res Bull; 2021 Nov; 176():174-183. PubMed ID: 34478811
[TBL] [Abstract][Full Text] [Related]
14. Tinospora cordifolia Suppresses Neuroinflammation in Parkinsonian Mouse Model.
Birla H; Rai SN; Singh SS; Zahra W; Rawat A; Tiwari N; Singh RK; Pathak A; Singh SP
Neuromolecular Med; 2019 Mar; 21(1):42-53. PubMed ID: 30644041
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
[TBL] [Abstract][Full Text] [Related]
16. Triple herbal extract DA-9805 exerts a neuroprotective effect via amelioration of mitochondrial damage in experimental models of Parkinson's disease.
Jeong JS; Piao Y; Kang S; Son M; Kang YC; Du XF; Ryu J; Cho YW; Jiang HH; Oh MS; Hong SP; Oh YJ; Pak YK
Sci Rep; 2018 Oct; 8(1):15953. PubMed ID: 30374025
[TBL] [Abstract][Full Text] [Related]
17. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
[TBL] [Abstract][Full Text] [Related]
18. Aucubin alleviates glial cell activation and preserves dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian mice.
Zhu YL; Sun MF; Jia XB; Zhang PH; Xu YD; Zhou ZL; Xu ZH; Cui C; Chen X; Yang XS; Shen YQ
Neuroreport; 2018 Sep; 29(13):1075-1083. PubMed ID: 29985188
[TBL] [Abstract][Full Text] [Related]
19. Activation of α7 nicotinic acetylcholine receptors protects astrocytes against oxidative stress-induced apoptosis: implications for Parkinson's disease.
Liu Y; Zeng X; Hui Y; Zhu C; Wu J; Taylor DH; Ji J; Fan W; Huang Z; Hu J
Neuropharmacology; 2015 Apr; 91():87-96. PubMed ID: 25486621
[TBL] [Abstract][Full Text] [Related]
20. Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease.
Ghosh A; Langley MR; Harischandra DS; Neal ML; Jin H; Anantharam V; Joseph J; Brenza T; Narasimhan B; Kanthasamy A; Kalyanaraman B; Kanthasamy AG
J Neuroimmune Pharmacol; 2016 Jun; 11(2):259-78. PubMed ID: 26838361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
